Yep 100%. Would seem incredibly risky to hold Disc when they are burning a lot of cash - minus $1 Million every 2 days is a lot in my books. Not even running a phase 3 which will require recruitment of one or two hundred EPP patients which may prove impossible in my opinion. Yet amazingly they are still valued at $2 Billion dollars - or 4 times more than Clinuvel who are generating $1 Million profits every week and growing, also already have FDA approval and are running a blockbuster phase 3 (plus ample cash to run a share buyback and provide a massive buffer). Which one should be worth $2 Billion and which should be worth $500 Million (including $200+ Million cash)?. Weird set up. Massive shorting here at CUV, looking like a takeover play, even today looking extremely manipulated with price 3% below VWAP - lots of circular trades IMO - really need that share buyback to remove some of that liquidity the hedge funds are trading back and forth.
All IMO DYOR
CUV Price at posting:
$10.07 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)